Antimalarials

"Antimalarials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)

Descriptor ID	D000962
MeSH Number(s)	D27.505.954.122.250.100.085
Concept/Terms	Antimalarials Antimalarials Antimalarial Agents Agents, Antimalarial Antimalarial Drugs Drugs, Antimalarial Anti-Malarials Anti Malarials

Below are MeSH descriptors whose meaning is more general than "Antimalarials".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiparasitic Agents [D27.505.954.122.250]
Antiprotozoal Agents [D27.505.954.122.250.100]
Antimalarials [D27.505.954.122.250.100.085]

Below are MeSH descriptors whose meaning is related to "Antimalarials".

Below are MeSH descriptors whose meaning is more specific than "Antimalarials".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antimalarials" by people in this website by year, and whether "Antimalarials" was a major or minor topic of these publications.

Bar chart showing 40 publications over 22 distinct years, with a maximum of 4 publications in 2011 and 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
1999	1	0	1
2000	0	1	1
2002	1	0	1
2004	2	1	3
2006	0	1	1
2008	0	1	1
2009	2	1	3
2010	2	0	2
2011	4	0	4
2012	1	0	1
2013	2	0	2
2014	4	0	4
2015	2	1	3
2016	1	1	2
2017	1	0	1
2018	0	1	1
2019	1	1	2
2020	1	0	1
2021	1	0	1
2022	1	0	1
2024	3	0	3

Below are the most recent publications written about "Antimalarials" by people in Profiles.

Rosado-Qui?ones AM, Col?n-Lorenzo EE, Pala ZR, Bosch J, Kudyba K, Kudyba H, Leed SE, Roncal N, Baerga-Ortiz A, Roche-Lima A, Gerena Y, Fidock DA, Roth A, Vega-Rodr?guez J, Serrano AE. Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs. Antimicrob Agents Chemother. 2024 Jun 05; 68(6):e0164323.

View in: PubMed
van Schalkwyk DA, Pratt S, Nolder D, Stewart LB, Liddy H, Muwanguzi-Karugaba J, Beshir KB, Britten D, Victory E, Rogers C, Millard J, Brown M, Nabarro LE, Taylor A, Young BC, Chiodini PL, Sutherland CJ. Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine. Clin Infect Dis. 2024 02 17; 78(2):445-452.

View in: PubMed
Upadhyay DB, Mokariya JA, Patel PJ, Patel SG, Das A, Nandi A, Nogales J, More N, Kumar A, Rajani DP, Narayan M, Kumar J, Banerjee S, Sahoo SK, Patel HM. Indole clubbed 2,4-thiazolidinedione linked 1,2,3-triazole as a potent antimalarial and antibacterial agent against drug-resistant strain and molecular modeling studies. Arch Pharm (Weinheim). 2024 Apr; 357(4):e2300673.

View in: PubMed
Roche-Lima A, Rosado-Qui?ones AM, Feliu-Maldonado RA, Figueroa-Gispert MDM, D?az-Rivera J, D?az-Gonz?lez RG, Carrasquillo-Carrion K, Nieves BG, Col?n-Lorenzo EE, Serrano AE. Antimalarial Drug Combination Predictions Using the Machine Learning Synergy Predictor (MLSyPred?) tool. Acta Parasitol. 2024 Mar; 69(1):415-425.

View in: PubMed
Olaleye OA, Zash R, Diseko M, Mayondi G, Mabuta J, Lockman S, Melton ML, Mmalane M, Makhema J, Shapiro RL. Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus?on birth outcomes in Botswana. Trop Med Int Health. 2022 11; 27(11):990-998.

View in: PubMed
Nyamwihura RJ, Zhang H, Collins JT, Crown O, Ogungbe IV. Nopol-Based Quinoline Derivatives as Antiplasmodial Agents. Molecules. 2021 Feb 14; 26(4).

View in: PubMed
Diaby V, Almutairi RD, Chen Z, Moussa RK, Berthe A. A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert Rev Pharmacoecon Outcomes Res. 2021 Feb; 21(1):159-168.

View in: PubMed
Hsia SH, Duran P, Lee ML, Davidson MB. Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.

View in: PubMed
Sowunmi A, Ntadom G, Akano K, Ibironke FO, Ayede AI, Agomo C, Folarin OA, Gbotosho GO, Happi C, Oguche S, Okafor HU, Meremikwu M, Agomo P, Ogala W, Watila I, Mokuolu O, Finomo F, Ebenebe JC, Jiya N, Ambe J, Wammanda R, Emechebe G, Oyibo W, Useh F, Aderoyeje T, Dokunmu TM, Alebiosu OT, Amoo S, Basorun OK, Wewe OA, Okafor C, Akpoborie O, Fatunmbi B, Adewoye EO, Ezeigwe NM, Oduola A. Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria. Infect Dis Poverty. 2019 Aug 06; 8(1):69.

View in: PubMed
Valliani S, Agasthi P, Westney G, Foreman M. Transfusion-Transmitted Plasmodium falciparum in a Patient With Sickle Cell Hemoglobinopathy. Ann Intern Med. 2018 09 18; 169(6):417-418.

View in: PubMed

People

Explore

Similar Concepts

Top Journals